Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM) — Form 3: Initial insider holdings
About this filing
Actinium Pharmaceuticals, Inc. (ATNM) filed Form 3 (initial insider holdings) with the SEC on Oct 16, 2026.
Key facts
Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.
More ATNM filings
- 4
Filed Oct 16, 2026
- ARS
Filed Oct 16, 2026
- DEF 14A
Filed Oct 16, 2026
- 8-K
Filed Oct 15, 2026
- S-8
Filed Oct 9, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.